[1]
Lee CT, Oldham JM. Interstitial Pneumonia with Autoimmune Features: Overview of proposed criteria and recent cohort characterization. Clinical pulmonary medicine. 2017 Sep:24(5):191-196. doi: 10.1097/CPM.0000000000000227. Epub
[PubMed PMID: 29276366]
Level 3 (low-level) evidence
[2]
Mikolasch TA, Garthwaite HS, Porter JC. Update in diagnosis and management of interstitial lung disease . Clinical medicine (London, England). 2017 Apr:17(2):146-153. doi: 10.7861/clinmedicine.17-2-146. Epub
[PubMed PMID: 28365626]
[3]
Jindal SK, Agarwal R. Autoimmunity and interstitial lung disease. Current opinion in pulmonary medicine. 2005 Sep:11(5):438-46
[PubMed PMID: 16093819]
Level 3 (low-level) evidence
[4]
Graney BA, Fischer A. Interstitial Pneumonia with Autoimmune Features. Annals of the American Thoracic Society. 2019 May:16(5):525-533. doi: 10.1513/AnnalsATS.201808-565CME. Epub
[PubMed PMID: 30695649]
[5]
Oldham JM,Adegunsoye A,Valenzi E,Lee C,Witt L,Chen L,Husain AN,Montner S,Chung JH,Cottin V,Fischer A,Noth I,Vij R,Strek ME, Characterisation of patients with interstitial pneumonia with autoimmune features. The European respiratory journal. 2016 Jun
[PubMed PMID: 27103387]
[6]
Koo SM, Uh ST. Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view. The Korean journal of internal medicine. 2017 Jul:32(4):600-610. doi: 10.3904/kjim.2016.212. Epub 2017 Jun 30
[PubMed PMID: 28704913]
[7]
Wallace B, Vummidi D, Khanna D. Management of connective tissue diseases associated interstitial lung disease: a review of the published literature. Current opinion in rheumatology. 2016 May:28(3):236-45. doi: 10.1097/BOR.0000000000000270. Epub
[PubMed PMID: 27027811]
Level 3 (low-level) evidence
[8]
Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal A, Galvin L, Inoue Y, Jenkins RG, Johkoh T, Kazerooni EA, Kitaichi M, Knight SL, Mansour G, Nicholson AG, Pipavath SNJ, Buendía-Roldán I, Selman M, Travis WD, Walsh S, Wilson KC, American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. American journal of respiratory and critical care medicine. 2018 Sep 1:198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST. Epub
[PubMed PMID: 30168753]
Level 1 (high-level) evidence
[9]
Kim DS. Interstitial lung disease in rheumatoid arthritis: recent advances. Current opinion in pulmonary medicine. 2006 Sep:12(5):346-53
[PubMed PMID: 16926650]
Level 3 (low-level) evidence
[10]
Capobianco J, Grimberg A, Thompson BM, Antunes VB, Jasinowodolinski D, Meirelles GS. Thoracic manifestations of collagen vascular diseases. Radiographics : a review publication of the Radiological Society of North America, Inc. 2012 Jan-Feb:32(1):33-50. doi: 10.1148/rg.321105058. Epub
[PubMed PMID: 22236892]
[12]
Coral-Alvarado P, Pardo AL, Castaño-Rodriguez N, Rojas-Villarraga A, Anaya JM. Systemic sclerosis: a world wide global analysis. Clinical rheumatology. 2009 Jul:28(7):757-65. doi: 10.1007/s10067-009-1144-9. Epub 2009 Mar 11
[PubMed PMID: 19277816]
[13]
McLaughlin V, Humbert M, Coghlan G, Nash P, Steen V. Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis. Rheumatology (Oxford, England). 2009 Jun:48 Suppl 3():iii25-31. doi: 10.1093/rheumatology/kep107. Epub
[PubMed PMID: 19487219]
[14]
Tansey D, Wells AU, Colby TV, Ip S, Nikolakoupolou A, du Bois RM, Hansell DM, Nicholson AG. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology. 2004 Jun:44(6):585-96
[PubMed PMID: 15186274]
[15]
Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis and rheumatism. 1999 May:42(5):899-909
[PubMed PMID: 10323445]
[16]
Bodolay E, Szekanecz Z, Dévényi K, Galuska L, Csípo I, Vègh J, Garai I, Szegedi G. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford, England). 2005 May:44(5):656-61
[PubMed PMID: 15716315]
[17]
Kim EA, Johkoh T, Lee KS, Ichikado K, Koh EM, Kim TS, Kim EY. Interstitial pneumonia in progressive systemic sclerosis: serial high-resolution CT findings with functional correlation. Journal of computer assisted tomography. 2001 Sep-Oct:25(5):757-63
[PubMed PMID: 11584237]
[18]
Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjögren's syndrome. Clinics in chest medicine. 1998 Dec:19(4):687-99, viii
[PubMed PMID: 9917960]
[19]
Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjögren syndrome. Chest. 2006 Nov:130(5):1489-95
[PubMed PMID: 17099028]
[20]
Geerts S, Wuyts W, Langhe E, Lenaerts J, Yserbyt J. Connective tissue disease associated interstitial pneumonia: a challenge for both rheumatologists and pulmonologists. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG. 2017:34(4):326-335. doi: 10.36141/svdld.v34i4.5894. Epub 2017 Apr 28
[PubMed PMID: 32476865]
[21]
Kim EA, Lee KS, Johkoh T, Kim TS, Suh GY, Kwon OJ, Han J. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics : a review publication of the Radiological Society of North America, Inc. 2002 Oct:22 Spec No():S151-65
[PubMed PMID: 12376608]
[22]
American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. American journal of respiratory and critical care medicine. 2002 Jan 15:165(2):277-304
[PubMed PMID: 11790668]
Level 3 (low-level) evidence
[23]
Wells AU, Hansell DM, Corrin B, Harrison NK, Goldstraw P, Black CM, du Bois RM. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax. 1992 Sep:47(9):738-42
[PubMed PMID: 1440471]
[24]
Kalchiem-Dekel O, Galvin JR, Burke AP, Atamas SP, Todd NW. Interstitial Lung Disease and Pulmonary Fibrosis: A Practical Approach for General Medicine Physicians with Focus on the Medical History. Journal of clinical medicine. 2018 Nov 24:7(12):. doi: 10.3390/jcm7120476. Epub 2018 Nov 24
[PubMed PMID: 30477216]
[25]
Colby TV. Pulmonary pathology in patients with systemic autoimmune diseases. Clinics in chest medicine. 1998 Dec:19(4):587-612, vii
[PubMed PMID: 9917955]
[26]
Tanoue LT. Pulmonary manifestations of rheumatoid arthritis. Clinics in chest medicine. 1998 Dec:19(4):667-85, viii
[PubMed PMID: 9917959]
[27]
Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis. The American review of respiratory disease. 1985 May:131(5):770-7
[PubMed PMID: 3873887]
[28]
Minai OA, Dweik RA, Arroliga AC. Manifestations of scleroderma pulmonary disease. Clinics in chest medicine. 1998 Dec:19(4):713-31, viii-ix
[PubMed PMID: 9917962]
[29]
Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. The American review of respiratory disease. 1990 Mar:141(3):727-33
[PubMed PMID: 2310101]
[30]
Deheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH, de Carvalho CR. Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment. American journal of respiratory and critical care medicine. 1996 Sep:154(3 Pt 1):794-9
[PubMed PMID: 8810621]
[31]
Johkoh T, Müller NL, Pickford HA, Hartman TE, Ichikado K, Akira M, Honda O, Nakamura H. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology. 1999 Aug:212(2):567-72
[PubMed PMID: 10429719]
[32]
Singh P, Thakur B, Mohapatra AK, Padhan P. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India. International journal of rheumatic diseases. 2019 Sep:22(9):1741-1745. doi: 10.1111/1756-185X.13666. Epub 2019 Jul 22
[PubMed PMID: 31328423]
[33]
Kadoya K, Togo S, Tulafu M, Namba Y, Iwai M, Watanabe J, Okabe T, Jin J, Kodama Y, Kitamura H, Ogura T, Kitamura N, Ikeo K, Takeda T, Kondo N, Takahashi K. Specific Features of Fibrotic Lung Fibroblasts Highly Sensitive to Fibrotic Processes Mediated via TGF-β-ERK5 Interaction. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 2019:52(4):822-837. doi: 10.33594/000000057. Epub
[PubMed PMID: 30946557]
[34]
Polverosi R, Maffesanti M, Dalpiaz G. Organizing pneumonia: typical and atypical HRCT patterns. La Radiologia medica. 2006 Mar:111(2):202-12
[PubMed PMID: 16671378]
[35]
Argiriadi PA, Mendelson DS. High resolution computed tomography in idiopathic interstitial pneumonias. The Mount Sinai journal of medicine, New York. 2009 Feb:76(1):37-52. doi: 10.1002/msj.20089. Epub
[PubMed PMID: 19170217]
[36]
Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. Journal of computer assisted tomography. 1999 Nov-Dec:23(6):941-8
[PubMed PMID: 10589572]
[37]
Remy-Jardin M, Remy J, Wallaert B, Bataille D, Hatron PY. Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology. 1993 Aug:188(2):499-506
[PubMed PMID: 8327704]
[38]
Fenlon HM, Doran M, Sant SM, Breatnach E. High-resolution chest CT in systemic lupus erythematosus. AJR. American journal of roentgenology. 1996 Feb:166(2):301-7
[PubMed PMID: 8553934]
[39]
Akira M, Hara H, Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients. Radiology. 1999 Feb:210(2):333-8
[PubMed PMID: 10207411]
[40]
Chartrand S, Fischer A. Management of connective tissue disease-associated interstitial lung disease. Rheumatic diseases clinics of North America. 2015 May:41(2):279-94. doi: 10.1016/j.rdc.2015.01.002. Epub 2015 Feb 3
[PubMed PMID: 25836643]
[41]
Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, Montero D, Pascual-Gómez E, Mola EM, Carreño L, Figueroa M, BIOBADASER Group. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis and rheumatism. 2005 Jun:52(6):1766-72
[PubMed PMID: 15934089]
[42]
Meyer KC. Immunosuppressive agents and interstitial lung disease: what are the risks? Expert review of respiratory medicine. 2014 Jun:8(3):263-6. doi: 10.1586/17476348.2014.880054. Epub 2014 Mar 20
[PubMed PMID: 24649876]
[43]
Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, Hirani N, Hubbard R, Lake F, Millar AB, Wallace WA, Wells AU, Whyte MK, Wilsher ML, British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee, Thoracic Society of Australia, New Zealand Thoracic Society, Irish Thoracic Society. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008 Sep:63 Suppl 5():v1-58. doi: 10.1136/thx.2008.101691. Epub
[PubMed PMID: 18757459]
[44]
Jee AS, Sheehy R, Hopkins P, Corte TJ, Grainge C, Troy LK, Symons K, Spencer LM, Reynolds PN, Chapman S, de Boer S, Reddy T, Holland AE, Chambers DC, Glaspole IN, Jo HE, Bleasel JF, Wrobel JP, Dowman L, Parker MJS, Wilsher ML, Goh NSL, Moodley Y, Keir GJ. Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand. Respirology (Carlton, Vic.). 2021 Jan:26(1):23-51. doi: 10.1111/resp.13977. Epub 2020 Nov 24
[PubMed PMID: 33233015]
[45]
Mathai SC, Danoff SK. Management of interstitial lung disease associated with connective tissue disease. BMJ (Clinical research ed.). 2016 Feb 24:352():h6819. doi: 10.1136/bmj.h6819. Epub 2016 Feb 24
[PubMed PMID: 26912511]
[46]
Flaherty KR,Wells AU,Cottin V,Devaraj A,Walsh SLF,Inoue Y,Richeldi L,Kolb M,Tetzlaff K,Stowasser S,Coeck C,Clerisme-Beaty E,Rosenstock B,Quaresma M,Haeufel T,Goeldner RG,Schlenker-Herceg R,Brown KK,INBUILD Trial Investigators., Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. The New England journal of medicine. 2019 Oct 31;
[PubMed PMID: 31566307]
[47]
Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM, SENSCIS Trial Investigators. Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. The New England journal of medicine. 2019 Jun 27:380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20
[PubMed PMID: 31112379]
[48]
Maher TM, Corte TJ, Fischer A, Kreuter M, Lederer DJ, Molina-Molina M, Axmann J, Kirchgaessler KU, Samara K, Gilberg F, Cottin V. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet. Respiratory medicine. 2020 Feb:8(2):147-157. doi: 10.1016/S2213-2600(19)30341-8. Epub 2019 Sep 29
[PubMed PMID: 31578169]
Level 1 (high-level) evidence
[49]
Yazdani A, Singer LG, Strand V, Gelber AC, Williams L, Mittoo S. Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2014 May:33(5):514-20. doi: 10.1016/j.healun.2014.01.858. Epub 2014 Jan 24
[PubMed PMID: 24630861]
Level 2 (mid-level) evidence
[50]
Atzeni F, Gerardi MC, Barilaro G, Masala IF, Benucci M, Sarzi-Puttini P. Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review. Expert review of clinical immunology. 2018 Jan:14(1):69-82. doi: 10.1080/1744666X.2018.1411190. Epub 2017 Dec 11
[PubMed PMID: 29202589]
[51]
Salinas M, Solomon JJ, Fernández Pérez ER. Connective Tissue Disease-Interstitial Lung Disease-Associated Mortality Rates and Years of Potential Life Lost in the United States. Chest. 2021 Oct:160(4):1368-1371. doi: 10.1016/j.chest.2021.03.034. Epub 2021 Aug 7
[PubMed PMID: 34625174]
[52]
Takizawa H, Suzuki N, Yanagawa T, Okazaki H, Satoh M, Akiyama N, Kohyama T, Ito K, Oka T. [Importance of interstitial lung disease in collagen vascular disease: analysis of outcome]. Nihon Kyobu Shikkan Gakkai zasshi. 1996 Nov:34(11):1177-81
[PubMed PMID: 8976070]
[53]
Travis WD, Hunninghake G, King TE Jr, Lynch DA, Colby TV, Galvin JR, Brown KK, Chung MP, Cordier JF, du Bois RM, Flaherty KR, Franks TJ, Hansell DM, Hartman TE, Kazerooni EA, Kim DS, Kitaichi M, Koyama T, Martinez FJ, Nagai S, Midthun DE, Müller NL, Nicholson AG, Raghu G, Selman M, Wells A. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. American journal of respiratory and critical care medicine. 2008 Jun 15:177(12):1338-47. doi: 10.1164/rccm.200611-1685OC. Epub 2008 Apr 3
[PubMed PMID: 18388353]
[54]
Imokawa S, Colby TV, Leslie KO, Helmers RA. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. The European respiratory journal. 2000 Feb:15(2):373-81
[PubMed PMID: 10706507]
[55]
Solomon JJ, Chartrand S, Fischer A. Current approach to connective tissue disease-associated interstitial lung disease. Current opinion in pulmonary medicine. 2014 Sep:20(5):449-56. doi: 10.1097/MCP.0000000000000081. Epub
[PubMed PMID: 25022317]
Level 3 (low-level) evidence
[56]
Fischer A, du Bois R. Interstitial lung disease in connective tissue disorders. Lancet (London, England). 2012 Aug 18:380(9842):689-98. doi: 10.1016/S0140-6736(12)61079-4. Epub
[PubMed PMID: 22901890]